Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma
Condition(s):Neuroblastoma; GanglioneuroblastomaLast Updated:October 10, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Neuroblastoma; GanglioneuroblastomaLast Updated:October 10, 2023Recruiting
Condition(s):Ganglioneuroblastoma; Localized Resectable Neuroblastoma; Localized Unresectable Neuroblastoma; Regional Neuroblastoma; Stage 4 Neuroblastoma; Stage 4S NeuroblastomaLast Updated:April 13, 2023Recruiting
Condition(s):Neuroblastoma; Ganglioneuroblastoma; GanglioneuromaLast Updated:November 7, 2023Recruiting
Condition(s):Ganglioneuroblastoma; NeuroblastomaLast Updated:February 29, 2024Active, not recruiting
Condition(s):Neuroblastoma; GanglioneuroblastomaLast Updated:January 5, 2021Recruiting
Condition(s):Ganglioneuroblastoma; High Risk NeuroblastomaLast Updated:March 14, 2023Active, not recruiting
Condition(s):Ganglioneuroblastoma; NeuroblastomaLast Updated:March 13, 2024Not yet recruiting
Condition(s):Ganglioneuroblastoma; Recurrent NeuroblastomaLast Updated:October 24, 2022Completed
Condition(s):Neuroblastoma; GanglioneuroblastomaLast Updated:June 29, 2023Active, not recruiting
Condition(s):Ganglioneuroblastoma, Nodular; NeuroblastomaLast Updated:November 21, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.